The carditis treatment market is witnessing growth due to the increasing prevalence of inflammatory and autoimmune heart diseases. Early diagnosis, advancements in imaging technologies, and improved awareness of cardiovascular health are supporting treatment adoption. The development of targeted therapies, biologics, and anti-inflammatory drugs is improving patient outcomes. https://www.databridgemarketresearch.com/reports/global-carditis-treatment-market